People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

116.60CHF
23 Dec 2014
Price Change (% chg)

CHF-2.00 (-1.69%)
Prev Close
CHF118.60
Open
CHF119.10
Day's High
CHF120.40
Day's Low
CHF116.40
Volume
383,671
Avg. Vol
512,231
52-wk High
CHF120.40
52-wk Low
CHF74.20

Search Stocks

Franco, Nicholas 

Brief Biography

Mr. Nicholas Franco has served as Member of the Management Board, Executive Vice President, Chief Business Development Officer at Actelion Ltd since 2011. He also serves as Senior Vice President, International Commercial Operations, at Axcan Pharma, France; Head of Market Access Region Europe for Novartis Pharma AG, Switzerland, where he held various management positions since 1991. Previous positions include President of Novartis Ophthalmics, Global Head, Business Development and Licensing Negotiations, and Global Head of Neuroscience Business Franchise. He is Graduate of McGill University, Canada, with a BSc in Biochemistry and a Master’s degree in Business Administration, Strategic Planning and Marketing.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks